Skip to content
healthcare.dev

ALDURAZYME

NDC 58468-0070, laronidase, injection, solution, concentrate, from Genzyme Corporation.

Product NDC
58468-0070
Status
Listed
Labeler
Genzyme Corporation
Dosage form
INJECTION, SOLUTION, CONCENTRATE
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA125058
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/58468-0070 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LARONIDASE2.9 mg/5mL

Pharmacologic classes

Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC]; alpha-Glucosidases [CS]

Package NDCNDC-11Package
58468-0070-1584680070015 mL in 1 VIAL, GLASS (58468-0070-1)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/a80ac249-cae4-41f3-88bb-344088b20e60
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=58468-0070

Use it

Look up 58468-0070 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/58468-0070 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 58468-0070. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.